PAYS - Paysign, Inc.
Paysign, Inc. (NASDAQ: PAYS - Get Free Report)'s stock price reached a new 52-week high on Thursday. The company traded as high as $15.09 and last traded at $14.95, with a volume of 873426 shares trading hands. The stock had previously closed at $14.36. Analyst Upgrades and Downgrades A number of research analysts have recently weighed
The best financial stocks to combat rising rates and inflation in Q4 may be those with superior growth and momentum, not traditional banks and brokerages. Persistent inflation and elevated interest rates raise the importance of finding companies capable of growing revenue and earnings despite tighter financial conditions. Consumer finance and digital payments offer secular growth opportunities as borrowing needs and increasingly digital financial behavior support demand.
Bank of America Corp DE purchased a new position in Paysign, Inc. (NASDAQ: PAYS) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 40,914 shares of the company's stock, valued at approximately $335,000. Bank of America Corp DE owned about 0.07%
Paysign, Inc. (NASDAQ: PAYS - Get Free Report)'s share price rose 7.1% during mid-day trading on Thursday. The stock traded as high as $14.27 and last traded at $14.44. Approximately 201,540 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 702,574 shares. The stock had previously closed at $13.48.
BlackRock Inc. bought a new position in Paysign, Inc. (NASDAQ: PAYS) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,079,208 shares of the company's stock, valued at approximately $25,219,000. BlackRock Inc. owned about 5.51% of Paysign as of its
Paysign NASDAQ: PAYS operates in two healthcare-focused businesses: payment services for plasma donors and pharmaceutical patient-affordability programs, Chief Financial Officer Jeff Baker said during a company presentation.
Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here is how Paysign, Inc. (PAYS) and Sezzle Inc. (SEZL) have performed compared to their sector so far this year.
Dimensional Fund Advisors LP increased its stake in shares of Paysign, Inc. (NASDAQ: PAYS) by 16.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 575,619 shares of the company's stock after purchasing an additional 82,736 shares during
Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Paysign NASDAQ: PAYS reported record second-quarter revenue, net income and adjusted EBITDA for 2026, driven primarily by continued expansion in its Patient Affordability business and improving utilization in its plasma donor compensation operations.
Paysign, Inc. (PAYS) Q2 2026 Earnings Call Transcript
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive pharma patient affordability offerings, financial technology products and integrated payment processing, today announced financial results for the second quarter 2026. “Paysign delivered a strong second quarter, achieving record revenue, net income, and adjusted EBITDA while continuing to expand margins,” said Mark Newcomer, President and CEO of Paysign. “Strong growth in o.
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss second quarter 2026 earnings at 5:00 p.m. Eastern time on Wednesday, August 5, 2026. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Click Here Replay: Dial-in: 877.660.68.
Paysign, Inc. (NASDAQ: [url="]PAYS[/url]), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platfo
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Planet MicroCap Las Vegas 2026.
Paysign, Inc. (NASDAQ: [url="]PAYS[/url]), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platfo
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Barrington Research Virtual Spring Investment Conference.
Paysign handily beat Wall Street analysts in the first quarter but didn't raise guidance. The stock looks cheap.